Patent · US Active

Targeting peptides and uses thereof

US10344052B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

HEALTH RESEARCH, INC. · US

Inventors

Gary J. Smith · Kingston, CA
Ryan Willard · Arbutus, US

Key dates

Filing date	Mar 14, 2014
Grant date	Jul 9, 2019
Priority date	—
Expiry date	Oct 31, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y204/02036
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are peptides, fusion proteins which include the peptide sequences, compositions comprising such peptides and fusion proteins, and methods for making and using the compositions. The peptides are characterized as being able to selectively bind to components of the endothelial compartment that are exposed during the period between 1 and 7 days after androgen deprivation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.